Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04210505 · ClinicalTrials.gov registry record · Phase 4
Nasal Decolonization of Dialysis Patients Noses
A Phase 4 study of Staphylococcus Aureus Infection, sponsored by Marin L. Schweizer, PhD.
- Active
- Registry status
- Phase 4
- Development phase
- 302
- Enrollment target
- 5
- Study locations
NCT04210505: Active Phase 4 study of Staphylococcus Aureus Infection, sponsored by Marin L. Schweizer, PhD.
NCT04210505 is a Phase 4 study of Staphylococcus Aureus Infection that is active but no longer recruiting, run by Marin L. Schweizer, PhD. The registered enrollment target is 302 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04210505, a Phase 4 study of Staphylococcus Aureus Infection, is active but no longer recruiting, sponsored by Marin L. Schweizer, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 302 participants
- Enrollment target
- 5
- Study locations
Study Summary
Hemodialysis patients are at high-risk for infections, specifically Staphylococcus aureus infections. The investigators propose to 1) implement a novel intervention (nasal povidone-iodine at each hemodialysis session) to prevent S. aureus infections using a stepped-wedge cluster randomized trial, and 2) evaluate the feasibility and acceptability of this intervention. If successful, this intervention can be used among hemodialysis patients, and evaluated in other high-risk patient populations to prevent S. aureus infections.
Primary Outcome
Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) definition: a Staphylococcus aureus positive blood specimen collected in the outpatient setting or within 1 calendar day after a hospital admission
Conditions Studied
Interventions
- OTHER Standard Care
- DRUG Povidone-Iodine Topical Ointment
Study Locations (5)
Georgia
- Emory Healthcare - Atlanta
Illinois
- University of Illinois Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Missouri
- Washington University - St Louis
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2024-01-31 |
| Phase | Phase 4 |
What the registry record for NCT04210505 still lists
NCT04210505 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Staphylococcus Aureus Infection appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT04210505 lists 5 locations in 5 states (Georgia, Illinois, Iowa).
Frequently Asked Questions
What is clinical trial NCT04210505 about?
NCT04210505 is a clinical study titled "Nasal Decolonization of Dialysis Patients Noses". Hemodialysis patients are at high-risk for infections, specifically Staphylococcus aureus infections. The investigators propose to 1) implement a novel intervention (nasal povidone-iodine at each hemodialysis session) to prevent S. aureus infections using a stepped-wedge cluster randomized trial, an...
What is the current status of trial NCT04210505?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 302 participants. The study started on 2020-09-29. Estimated completion is 2024-01-31.
What conditions does trial NCT04210505 study?
This clinical trial studies the following conditions: Staphylococcus Aureus Infection.
What interventions are being tested in trial NCT04210505?
The interventions under investigation include: Standard Care (OTHER), Povidone-Iodine Topical Ointment (DRUG).
Who is sponsoring clinical trial NCT04210505?
This trial is sponsored by Marin L. Schweizer, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04210505 being conducted?
This trial has 5 study locations across Georgia, Illinois, Iowa, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcus Aureus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04210505's enrollment target sits among peer trials
302 266th of 2000 higher than 1,734 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI